Skip to content
Home/Companies/MedTech/Resistell
RE

Resistell

MedTech·Switzerland·Active·7yr hold

Resistell is a MedTech company, headquartered in Switzerland.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Resistell?

Resistell is currently owned by TRUMPF Venture through TRUMPF Venture Fund I (2016 vintage), since 2019.

Hand-verified · updated 2026-07-03

TRUMPF Venture
Investor
TRUMPF Venture
TRUMPF Venture Fund I · 2016 · VC

Key facts

HQSwitzerland
SectorMedTech
StatusActive

More from TRUMPF Venture Fund I

Other portfolio companies in the same fund.

Ascend Elements
Active
EnergyUnited States· 2021
Carbice
Active
IndustrialsUnited States· 2021
CYR3CON
Exited 2022
CybersecurityUnited States· 2021
to
kiutra
Active
Deep TechGermany· 2021
L7 Defense
Active
CybersecurityIsrael· 2021
Peers Solutions
Exited 2025
SoftwareGermany· 2020

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings